Join

or

Existing user? Login

  • Category M prices to increase by £15m per month from August 2019, announces PSNC

    Category M reimbursement prices are to increase by £15m per month from August 2019, the Pharmaceutical Services Negotiating Committee (PSNC) has announced following discussions with the Department of Health and Social Care (DHSC).

    The price increase will help to ensure that the overall amount of margin delivered during the 2019/20 financial year is the agreed annual sum of £800m and should help to ease immediate contractor cashflow issues, the PSNC explained.

    The Single Activity Fee will also rise by 1p to £1.27 per item.

    “The past few months have been incredibly difficult for many community pharmacy contractors, and this has in part been caused by the need to keep Category M reimbursement prices low following excess margins earned in previous financial years,” said Simon Dukes, chief executive of the PSNC.

    “These August price increases are being made to try to correct margin delivery for this financial year and this should bring some relief for contractors.”

    Despite the increases, Dukes said the PSNC was concerned about the impact of cashflow difficulties on pharmacies and was pressing the DHSC to make improvements to the funding and margin distribution systems to try to avoid future problems.

    In April 2019, Category M prices increased by £10m, but the April 2019 reimbursement levels were lower than anticipated, which meant that contractors did not see the positive cashflow impact that they expected, the PSNC said.

     

     

  • Boots and PDA Union sign their first voluntary recognition agreement

    The Pharmacists’ Defence Association (PDA) Union has signed its first voluntary recognition agreement with Boots.

    The formal agreement means that the PDA Union, which now represents store-based Boots pharmacists and pre-registration pharmacists, will negotiate the annual pay for these roles within Boots, starting with the forthcoming annual pay review for the financial year 2019/2020.

    A joint negotiating board made up of a subset of PDA Union representatives will exist negotiations over pay, hours and holidays.

    The agreement includes a list of policy items, including bonus payments and human resource policies, which Boots will inform the PDA Union about if there are any changes.

     

  • pause slideshow

Jerome Bertin, general manager of SecurMed, which manages the UK’s medicines verification system,

It is time to enforce FMD compliance, says European Medicines Verification Organisation

The body that runs the Falsified Medicines Directive says medicines regulators in individual countries should begin enforcing its compliance.

Methotrexate

EMA makes recommendations to reduce methotrexate dosing errors

Only doctors with expertise in using methotrexate-containing medicines should be able to prescribe them, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has recommended.

Read More

Kidney ultrasound

SGLT2 inhibitor lowers risk of kidney failure in type 2 diabetesSubscription

Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.

Older person using smartphone

App helps patients cut opioid use after knee replacementSubscription

Patients who underwent knee replacement who used an app to monitor their analgesic use had better pain control and took fewer opioids post surgery, study results show.

Xanax

Concerns raised over non-medical alprazolam useSubscription

The benzodiazepine alprazolam is being obtained for non-medical use in the UK, particularly among young people, a survey has found.

Glucose test for diabetes

Immunotherapy delays type 1 diabetes mellitus in high-risk individualsSubscription

Certain individuals at high risk of developing type 1 diabetes mellitis can delay progression to clinical disease by two years or more with a two-week course of teplizumab, according to a phase II study Source: Shutterstock.com

Vitamin D fish oil supplement

Vitamin D not protective against cardiovascular eventsSubscription

Vitamin D supplementation is not associated with a reduced risk of major cardiovascular events, a meta-analysis suggests.

Methadone

Alzheimer’s drug reduces illicit opioid use in methadone recipientsSubscription

People who take methadone use fewer illicit opioids when galantamine is added to their therapy, research shows.

More research briefings

Pharm2U robot

Inside Pharmacy2USubscription

From controversial marketing campaigns to fears that its vast dispensing facilities will quash high street pharmacy businesses, Pharmacy2U’s rise has not gone unnoticed.

Antimicrobal resistance

Emergency antibiotic supplies double despite concern over AMRSubscription

As the number of antibiotics supplied through the NHS Urgent Medicine Supply Advanced Service increases, concerns are growing over its impact on antimicrobial resistance.

More features

Pharmaceutical Journal opioid infographic

Opioids in England: crisis averted? Subscription

Despite a 20% increase in opioid prescriptions per 1,000 population over the past decade, there are signs that a US-style opioid epidemic may have been averted.

More infographics